AI assistant
Sending…
MERIT MEDICAL SYSTEMS INC — Director's Dealing 2017
Apr 19, 2017
31049_dirs_2017-04-18_799a0942-5447-42d7-9a76-ebe7be4c6be8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MERIT MEDICAL SYSTEMS INC (MMSI)
CIK: 0000856982
Period of Report: 2017-04-14
Reporting Person: Birkett Bernard (Chief Financial Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-04-14 | Non-qualified stock options (right to buy) | $28.20 | A | 50000 | Acquired | 2024-04-14 | Common Stock (50000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, No Par Value | 1075 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-qualified stock options (right to buy) | $13.75 | 2018-08-11 | Common Stock (10000) | 10000 | Direct |
| Non-qualified stock options (right to buy) | $12.06 | 2021-10-04 | Common Stock (10000) | 10000 | Direct |
| Non-qualified stock options (right to buy) | $17.27 | 2022-02-13 | Common Stock (25000) | 25000 | Direct |
| Non-qualified stock options (right to buy) | $16.05 | 2023-01-28 | Common Stock (25000) | 25000 | Direct |
Footnotes
F1: Becomes exercisable in equal annual installments of 20% commencing 08/11/12.
F2: Becomes exercisable in equal annual installments of 20% commencing 10/04/15.
F3: Becomes exercisable in equal annual installments of 20% commencing 02/13/16.
F4: Becomes exercisable in equal annual installments of 20% commencing 01/28/17.
F5: Becomes exercisable in equal annual installments of 20% commencing 04/14/18.
More from MERIT MEDICAL SYSTEMS INC
Regulatory Filings
2026
May 29
Declaration of Voting Results & Voting Rights Announcements
2026
May 19
Share Issue/Capital Change
2026
May 15
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 13
M&A Activity
2026
Apr 1
Annual Report
2026
Mar 31